%0 Journal Article
%T Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope
%A A. Cachot
%A C. Costa Nunes
%A C. Jandus
%A D. E. Speiser
%A D. Rimoldi
%A E. Romano
%A H. Maby-El Hajjami
%A J.-P. Rivals
%A L. Cagnon
%A L. Derr¨¦
%A M. Braun
%A M. P. Protti
%A O. Michielin
%A P. Baumgaertner
%A P. Marcos Mond¨¦jar
%A P. Romero
%A S. Abed Maillard
%A S. Gnjatic
%J Archive of "Oncoimmunology".
%D 2016
%R 10.1080/2162402X.2016.1216290
%K CpG-B
%K HLA-DR7
%K long synthetic peptide
%K malignant melanoma
%K NY-ESO-1
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087303/